• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

CDC Calls Continued Rise in Cases of STIs “Alarming”

CDC Calls Continued Rise in Cases of STIs “Alarming”

by Miriam Bergeret, MSc | May 5, 2023 | Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

Health inequities and disrupted STI testing and care during the pandemic continued to contribute to a rise in cases in 2021.

This content is for Paid Members only.
Login Register
Early in Pandemic, HIV Testing Dropped Sharply, but Quickly Rebounded

Early in Pandemic, HIV Testing Dropped Sharply, but Quickly Rebounded

by Glenn S. Demby | Jan 26, 2023 | Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

A recent CDC report concludes that disruptions to HIV testing due to the COVID-19 pandemic compromised America’s ability to prevent the disease.

This content is for Paid Members only.
Login Register
New Insight into Deaths of US Cancer Patients Due to COVID-19

New Insight into Deaths of US Cancer Patients Due to COVID-19

by Rachel Muenz | Oct 4, 2022 | News

Recent study provides new details on how COVID-19 impacted cancer deaths in the US early in the pandemic and which groups were most affected.

Inadequate Reimbursement Threatens Monkeypox Lab Testing Response

Inadequate Reimbursement Threatens Monkeypox Lab Testing Response

by Glenn S. Demby | Sep 30, 2022 | Laboratory Industry Report, Reimbursement-lir

ACLA and public health experts warn that current reimbursement rates will hamper US efforts to contain monkeypox spread.

This content is for Paid Members only.
Login Register
FDA to Issue Emergency Use Authorization for Monkeypox Tests

FDA to Issue Emergency Use Authorization for Monkeypox Tests

by Glenn S. Demby | Sep 13, 2022 | FDA-nir, National Lab Reporter

In a move to expand access to lab testing for monkeypox, HHS has authorized the FDA to issue EUAs for in vitro diagnostic tests for the virus.

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com